Atlas Trials

B-cell Malignancy, Low-grade

2 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch B-cell Malignancy, Low-grade

RecordFirmDate
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome (NCT02269592)Dana-Farber Cancer Institute2014-08-01
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors (NCT01618136)Eisai Limited2012-01-01

Track B-cell Malignancy, Low-grade automatically

Every clearance here is in the API, with alerts when new ones post.